Allopurinol for chronic stable angina: old drug, new tricks?
Open Access
- 8 June 2010
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 375 (9732), 2126-2127
- https://doi.org/10.1016/s0140-6736(10)60578-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trialThe Lancet, 2010
- Effect of PCI on Quality of Life in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2008
- Prevalence of Angina in Women Versus MenCirculation, 2008
- Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolutionHeart, 2006
- Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and MenJAMA, 2006
- Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failureHeart, 2005
- Metabolic manipulation in ischaemic heart disease, a novel approach to treatmentEuropean Heart Journal, 2004
- Uric Acid and Survival in Chronic Heart FailureCirculation, 2003
- Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trialThe Lancet, 2002
- Allopurinol enhances adenine nucleotide levels and improves myocardial function in isolated hypoxic rat heart.Biochemistry (Moscow), 2001